TLR4 and Parkinson disease: Several studies utilising 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; an established PD toxin model) demonstrate that TLR4 knock-out in mice attenuates the MPTP-induced inflammation, PD pathology and symptoms [62–64].